A meeting ground for people with Young Onset Parkinson's Disease
Latest Updates
Placebo effect in PD Clinical Trials defined
People with PD show a well-known placebo effect in clinical trials. Using PET scans, a new study indicates that this is a physiological, biochemical response to the _expectation_ of a therapeutic benefit. Four groups of subjects were told that they had a 25%, 50%, 75%, or 100% chance they would receive levodopa/carbidopa vs. placebo; in fact, all received placebo. The 75% group had a dopamine release in the areas of the brain typically involved in PD. [4 Aug 2010]
Sergey Brin profiled in Wired magazine
In the July 2010 issue, this article describes very clearly how Brin is working to drive the genetic analysis for PD via the company 23and Me. The co-founder of Google believes that the association algorithms they developed will have traction in the analysis of symptoms and genes. The program has enrolled nearly 5000 people with a target of 10,000. [4 Aug 2010]
CPG Meetings Ahead
The June and July Monthly meetings have been rolled back into the Annual Picnic for all CPG family and friends, which will be on July 17th. Please watch for details and RSVP by eVite.
Parkinson's News Stream
 Washington Post | VA expands its list of Agent Orange ills Times Herald-Record CARMEL — The Department of Veterans Affairs has added three diseases — Parkinson's disease, chronic b-cell leukemia and ischemic heart ... VA eases rules allowing Vietnam vets to get treatment for Agent Orange exposure VA Sets New Benefit Rules for Agent Orange-Related Ilnesses Aging vets' costs concern Obama's deficit co-chair |
Santhera Pharmaceuticals Holding AG: Santhera and Ipsen Enter into Licensing ... Reuters (press release) This first-in-class compound is currently under investigation for the treatment of levodopa-induced dyskinesia in Parkinson's Disease. ... Santhera Reports 2010 Interim Financial Results with Significant Reduction in ... Ipsen, Santhera Agree On Fipamezole License Outside North America, Japan Santhera, Ipsen ink fipamezole pact |
Parkinson's program Sioux Falls Argus Leader An educational program about Parkinson's disease for health care professsionals is planned for 1 to 2 pm Sept. 13 at Dow Rummel Village-Chapel, ... |
Powered By: 
